Zoetis
Enviracor J-5
Enviracor J-5
Couldn't load pickup availability
Enviracor J-5 Features & Benefits
-
Provides a safe, effective way to help control clinical signs associated with E. coli mastitis
- Research indicated Enviracor J-5 can provide up to $57 additional income per cow, per lactation, when incorporated into a dry off routine
- In a study, Enviracor J-5 shortened the duration of E. coli mastitis by 41%
Directions for Use:Â
Shake well. Three doses are required. Administer each 5-mL dose subcutaneously, one hand-width cranial to the shoulder. Vaccinate cows or heifers at 7 and 8 months of gestation followed by the third dose within two weeks postpartum.
Precautions:Â
Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not vaccinate within 60 days before slaughter. Local swelling occasionally occurs and may persist at the injection site. Contains thimerosal as a preservative. Do not mix with other products. In case of human exposure, contact a physician. In case of anaphylactoid reactions, epinephrine should be administered immediately.
Manufacturer and/or Label Information
Manufacturer and/or Label Information
Dimensions
Dimensions
Care information
Care information
Let customers speak for us
